Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.2779 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0012 | 0 | 0.5 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.2779 | 1 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.1033 | 0.3692 | 0.3692 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.2779 | 1 | 0.5 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.2779 | 1 | 1 |
Toxoplasma gondii | fructose-bisphospatase II | 0.2779 | 1 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.1033 | 0.3692 | 0.3692 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.2779 | 1 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.2779 | 1 | 0.5 |
Trypanosoma brucei | sedoheptulose-1,7-bisphosphatase | 0.1033 | 0.3692 | 0.3692 |
Leishmania major | 0.2779 | 1 | 1 | |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.2779 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.